Toward an Effective Ebola Virus Vaccine
Open Access
- 14 January 2017
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 68 (1) , 371-386
Abstract
Long-term control of viral outbreaks requires the use of vaccines to impart acquired resistance and ensuing protection. In the wake of an epidemic, established immunity against a particular disease can limit spread and significantly decrease mortality. Creation of a safe and efficacious vaccine against Ebola virus (EBOV) has proven elusive so far, but various inventive strategies are now being employed to counteract the threat of outbreaks caused by EBOV and related filoviruses. Here, we present a current overview of progress in the field of Ebola virus vaccine development.Keywords
This publication has 54 references indexed in Scilit:
- Evaluation of Convalescent Plasma for Ebola Virus Disease in GuineaNew England Journal of Medicine, 2016
- Ebola Virus Transmission in Guinea PigsJournal of Virology, 2015
- Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and NamesViruses, 2014
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMappNature, 2014
- Characterization of the Envelope Glycoprotein of a Novel Filovirus, Lloviu VirusJournal of Virology, 2014
- Discovery of an Ebolavirus-Like Filovirus in EuropePLOS Pathogens, 2011
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal ruleNature Reviews Microbiology, 2009
- Disease modeling for Ebola and Marburg virusesDisease Models & Mechanisms, 2009
- Pathogenesis of Experimental Ebola Virus Infection in Guinea PigsThe Journal of Infectious Diseases, 1999
- A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic FeverThe Journal of Infectious Diseases, 1998